Drugmakers Pledge Not To Release COVID-19 Vaccine Until Proven Safe
In a letter obtained by the Wall Street Journal, drugmakers say they won't bow to political pressure to release a COVID-19 vaccine by election day.
A group of drugmakers working on COVID-19 vaccines say they won't market the medicine until the drug is safe and proven effective.
Over the last week, concern has grown from some drugmakers feeling pressure from the Trump administration to release a vaccine before the presidential election on November 3. However, in a letter obtained by the Wall Street Journal, the pharmaceutical companies say they will not release any drug until trials prove the medicine is safe for people to use. The Journal quotes one CEO saying, "We will not cut corners."
News of the safety pledge comes just days after the CDC told state officials across the country to be ready to distribute a vaccine to health care workers and high-risk groups as soon as late October, ramping up expectations.
The Food and Drug Administration, however, said it would not allow for any vaccines to hit the market until they are proven to be at least 50 percent effective compared to a placebo.
Companies including Moderna, Pfizer, AstraZeneca and Johnson & Johnson have joined the pledge and several are in Phase 3 of their trials. The drugmakers said they will submit applications for government emergency-use authorization of vaccines based only on, quote, “substantial evidence of safety and efficacy.”
Phase 3 is the final stage of testing and signals whether the drug can actually reduce the rate of a disease.
Contains footage from CNN.
How you can clean the air to protect yourself from COVID
People can remove harmful aerosol particles, like the virus that causes COVID, from the air on their own terms.
Moderna defends vax price hike, despite billions in taxpayer funding
The company is planning to raise the price of its COVID-19 vaccine from about $26 per dose up to $130 per dose.
What living with long COVID is really like
Scripps News talked to a dozen people with long-term COVID symptoms about their current experience and their hope for the future.
Potential TikTok ban could limit small businesses' reach
“I would not be where I'm at right now without TikTok,” one small business owner said.
GOP lawmakers in Kentucky override transgender bill veto
Kentucky lawmakers have pushed out a veto of a bill that would regulate personal aspects of transgender care for young people.
Judge upholds Boy Scouts' $2.4 billion bankruptcy plan
The plan aims to settle tens of thousands of claims made by men who said they were sexually abused as child Scouts.